87 related articles for article (PubMed ID: 21278618)
1. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.
Peyron F; Garweg JG; Wallon M; Descloux E; Rolland M; Barth J
Pediatr Infect Dis J; 2011 Jul; 30(7):597-600. PubMed ID: 21278618
[TBL] [Abstract][Full Text] [Related]
2. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
[TBL] [Abstract][Full Text] [Related]
3. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
4. Neurologic and developmental outcome in treated congenital toxoplasmosis.
Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
[TBL] [Abstract][Full Text] [Related]
5. Geographic difference in outcomes of congenital toxoplasmosis.
Vasconcelos-Santos DV; Queiroz Andrade GM
Pediatr Infect Dis J; 2011 Sep; 30(9):816-7; author reply 817. PubMed ID: 21849862
[No Abstract] [Full Text] [Related]
6. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations in congenital toxoplasmosis.
Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
[TBL] [Abstract][Full Text] [Related]
8. [Congenital ocular toxoplasmosis--ocular manifestations and prognosis after early diagnosis of infection].
Garweg JG; Kodjikian L; Peyron F; Binquet C; Fleury J; Grange JD; Quantin C; Wallon M
Klin Monbl Augenheilkd; 2005 Sep; 222(9):721-7. PubMed ID: 16175482
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
[TBL] [Abstract][Full Text] [Related]
10. [Congenital toxoplasmosis: long-term ophthalmologic follow-up praised by patients].
Beraud L; Rabilloud M; Fleury J; Wallon M; Peyron F
J Fr Ophtalmol; 2013 Jun; 36(6):494-8. PubMed ID: 23428138
[TBL] [Abstract][Full Text] [Related]
11. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey.
Nirmalan PK; Tielsch JM; Katz J; Thulasiraj RD; Krishnadas R; Ramakrishnan R; Robin AL
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2308-12. PubMed ID: 15980215
[TBL] [Abstract][Full Text] [Related]
12. Quality of life assessment in ocular toxoplasmosis in a Colombian population.
de-la-Torre A; González-López G; Montoya-Gutiérrez JM; Marín-Arango V; Gómez-Marín JE
Ocul Immunol Inflamm; 2011 Aug; 19(4):262-6. PubMed ID: 21770804
[TBL] [Abstract][Full Text] [Related]
13. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study.
Klein BE; Moss SE; Klein R; Lee KE; Cruickshanks KJ
Ophthalmology; 2003 Apr; 110(4):644-50. PubMed ID: 12689880
[TBL] [Abstract][Full Text] [Related]
14. Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.
Nutheti R; Keeffe JE; Shamanna BR; Nirmalan PK; Krishnaiah S; Thomas R
Ophthalmology; 2007 Aug; 114(8):1552-7. PubMed ID: 17678693
[TBL] [Abstract][Full Text] [Related]
15. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh.
Nutheti R; Shamanna BR; Nirmalan PK; Keeffe JE; Krishnaiah S; Rao GN; Thomas R
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4742-8. PubMed ID: 17065482
[TBL] [Abstract][Full Text] [Related]
16. Vision and quality-of-life.
Brown GC
Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of children with congenital toxoplasmosis.
Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence.
Wallon M; Garweg JG; Abrahamowicz M; Cornu C; Vinault S; Quantin C; Bonithon-Kopp C; Picot S; Peyron F; Binquet C
Pediatrics; 2014 Mar; 133(3):e601-8. PubMed ID: 24534412
[TBL] [Abstract][Full Text] [Related]
19. [Visual function and quality of life in patients with age-related maculopathy: results of the Münster Age and Retina Study (MARS)].
Fuhs A; Dasch B; Behrens T; Meister A; Krause K; Pauleikhoff D; Hense HW
Klin Monbl Augenheilkd; 2005 Aug; 222(8):649-54. PubMed ID: 16118746
[TBL] [Abstract][Full Text] [Related]
20. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.
Delair E; Monnet D; Grabar S; Dupouy-Camet J; Yera H; Brézin AP
Am J Ophthalmol; 2008 Dec; 146(6):851-5. PubMed ID: 18723143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
